X-72676175-A-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_002637.4(PHKA1):c.538-25T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0109 in 1,113,170 control chromosomes in the GnomAD database, including 363 homozygotes. There are 4,473 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.012 ( 34 hom., 445 hem., cov: 22)
Exomes 𝑓: 0.011 ( 329 hom. 4028 hem. )
Consequence
PHKA1
NM_002637.4 intron
NM_002637.4 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.697
Publications
0 publications found
Genes affected
PHKA1 (HGNC:8925): (phosphorylase kinase regulatory subunit alpha 1) Phosphorylase kinase is a polymer of 16 subunits, four each of alpha, beta, gamma and delta. The alpha subunit includes the skeletal muscle and hepatic isoforms, and the skeletal muscle isoform is encoded by this gene. The beta subunit is the same in both the muscle and hepatic isoforms, and encoded by one gene. The gamma subunit also includes the skeletal muscle and hepatic isoforms, which are encoded by two different genes. The delta subunit is a calmodulin and can be encoded by three different genes. The gamma subunits contain the active site of the enzyme, whereas the alpha and beta subunits have regulatory functions controlled by phosphorylation. The delta subunit mediates the dependence of the enzyme on calcium concentration. Mutations in this gene cause glycogen storage disease type 9D, also known as X-linked muscle glycogenosis. Alternatively spliced transcript variants encoding different isoforms have been identified in this gene. A pseudogene has been found on chromosome 1.[provided by RefSeq, Feb 2010]
PHKA1 Gene-Disease associations (from GenCC):
- glycogen storage disease IXdInheritance: XL, AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.69).
BP6
Variant X-72676175-A-G is Benign according to our data. Variant chrX-72676175-A-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 258786.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0982 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| PHKA1 | NM_002637.4 | c.538-25T>C | intron_variant | Intron 5 of 31 | ENST00000373542.9 | NP_002628.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| PHKA1 | ENST00000373542.9 | c.538-25T>C | intron_variant | Intron 5 of 31 | 1 | NM_002637.4 | ENSP00000362643.4 |
Frequencies
GnomAD3 genomes AF: 0.0121 AC: 1342AN: 110821Hom.: 34 Cov.: 22 show subpopulations
GnomAD3 genomes
AF:
AC:
1342
AN:
110821
Hom.:
Cov.:
22
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0289 AC: 5261AN: 182034 AF XY: 0.0274 show subpopulations
GnomAD2 exomes
AF:
AC:
5261
AN:
182034
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0108 AC: 10837AN: 1002303Hom.: 329 Cov.: 21 AF XY: 0.0141 AC XY: 4028AN XY: 286567 show subpopulations
GnomAD4 exome
AF:
AC:
10837
AN:
1002303
Hom.:
Cov.:
21
AF XY:
AC XY:
4028
AN XY:
286567
show subpopulations
African (AFR)
AF:
AC:
58
AN:
24671
American (AMR)
AF:
AC:
2983
AN:
35061
Ashkenazi Jewish (ASJ)
AF:
AC:
210
AN:
18741
East Asian (EAS)
AF:
AC:
3426
AN:
29795
South Asian (SAS)
AF:
AC:
2824
AN:
51724
European-Finnish (FIN)
AF:
AC:
193
AN:
40323
Middle Eastern (MID)
AF:
AC:
8
AN:
3883
European-Non Finnish (NFE)
AF:
AC:
363
AN:
755113
Other (OTH)
AF:
AC:
772
AN:
42992
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
346
693
1039
1386
1732
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
150
300
450
600
750
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0121 AC: 1345AN: 110867Hom.: 34 Cov.: 22 AF XY: 0.0134 AC XY: 445AN XY: 33105 show subpopulations
GnomAD4 genome
AF:
AC:
1345
AN:
110867
Hom.:
Cov.:
22
AF XY:
AC XY:
445
AN XY:
33105
show subpopulations
African (AFR)
AF:
AC:
106
AN:
30539
American (AMR)
AF:
AC:
617
AN:
10404
Ashkenazi Jewish (ASJ)
AF:
AC:
33
AN:
2642
East Asian (EAS)
AF:
AC:
375
AN:
3502
South Asian (SAS)
AF:
AC:
119
AN:
2515
European-Finnish (FIN)
AF:
AC:
23
AN:
5929
Middle Eastern (MID)
AF:
AC:
0
AN:
217
European-Non Finnish (NFE)
AF:
AC:
37
AN:
52938
Other (OTH)
AF:
AC:
35
AN:
1498
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
44
88
133
177
221
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Jun 29, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Dec 15, 2015
Mayo Clinic Laboratories, Mayo Clinic
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
not specified Benign:1
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
Splicevardb
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.